Topic: drug discovery

Sydney, Australia's business district.

Mesoblast reaches milestone on Temcell with Japan partner JCR

Australia's Mesoblast will make the leap from drug discovery as Japanese partner JCR Pharmaceutical receivedapprovalto begin sales of an off-the-shelf allogeneic, or regenerative, medical product, Temcell, based on Mesoblast technology, theSydney Morning Heraldreports.